AAVANTI

Welcome to the Brand page for “AAVANTI”, which is offered here for Biological treatment for use for clinical, medicinal and the therapeutic treatment of friedreich's ataxia and genetic disorders; biological preparations for the treatment of friedreich's ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of friedreich's ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of friedreich's ataxia; biological drugs for treatment of genetic diseases and friedreich's ataxia; biological drugs for use in treating friedreich's ataxia and autoimmunity disorders and diseases; gene therapy products, therapeutics for the treatment of friedreich's ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of friedreich's ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for friedreich's ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents;.

Its status is currently believed to be active. Its class is unavailable. “AAVANTI” is believed to be currently owned by “AAVANTIBIO, INC.”

Owner:
AAVANTIBIO, INC.
Owner Details
Description:
Biological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents;
Categories: BIOLOGICAL TREATMENT USE